BioCentury | Jan 5, 2019
Finance

Ready to launch

...syndrome (MDS)-associated anemia and transfusion-dependent β-thalassemia Submit BLA and MAA 1H19 Acer Therapeutics Inc. (NASDAQ:ACER) ACER-001...
BioCentury | Jul 7, 2017
Company News

Acer finds public path via Opexa merger

...Hospitals system. Edsivo has Orphan Drug designation for vascular Ehlers-Danlos syndrome. Acer’s pipeline also includes ACER-001...
...Therapeutics Inc. , Cambridge, Mass. Opexa Therapeutics Inc. (NASDAQ:OPXA), The Woodlands, Texas Business: Endocrine/Metabolic Jaime De Leon ACER-001 ACER-002 celiprolol Edsivo imilecleucel-T T-cell...
BioCentury | Jul 3, 2017
Company News

Acer finds public path via Opexa merger

...Hospitals system. Edsivo has Orphan Drug designation for vascular Ehlers-Danlos syndrome. Acer’s pipeline also includes ACER-001...
...expanded ex vivo with myelin-associated peptides. Opexa gained $0.50 (77%) to $1.15 on Monday. Jaime De Leon ACER-001 ACER-002 imilecleucel-T OPX-212 Tcelna Acer...
Items per page:
1 - 3 of 3